SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-034315
Filing Date
2021-02-09
Accepted
2021-02-09 16:06:11
Documents
14
Period of Report
2021-02-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d129497d8k.htm   iXBRL 8-K 25920
2 EX-99.1 d129497dex991.htm EX-99.1 102766
6 GRAPHIC g129497logo.jpg GRAPHIC 5796
  Complete submission text file 0001193125-21-034315.txt   268248

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dcph-20210209.xsd EX-101.SCH 3071
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dcph-20210209_lab.xml EX-101.LAB 17372
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dcph-20210209_pre.xml EX-101.PRE 10953
7 EXTRACTED XBRL INSTANCE DOCUMENT d129497d8k_htm.xml XML 3227
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 21606404
SIC: 2834 Pharmaceutical Preparations